Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Mallinckrodt
Express Scripts
Accenture
US Department of Justice
Boehringer Ingelheim
Fish and Richardson
Dow
Medtronic

Generated: April 23, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: INSULIN GLULISINE RECOMBINANT

« Back to Dashboard

INSULIN GLULISINE RECOMBINANT

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi Aventis Us APIDRA insulin glulisine recombinant INJECTABLE;IV (INFUSION), SUBCUTANEOUS 021629 NDA Sanofi-Aventis U.S. LLC N 0088-2500-33
Sanofi Aventis Us APIDRA insulin glulisine recombinant INJECTABLE;IV (INFUSION), SUBCUTANEOUS 021629 NDA Sanofi-Aventis U.S. LLC N 0088-2502-05
Sanofi Aventis Us APIDRA SOLOSTAR insulin glulisine recombinant INJECTABLE;SUBCUTANEOUS 021629 NDA Sanofi-Aventis U.S. LLC N 0088-2500-33
Sanofi Aventis Us APIDRA SOLOSTAR insulin glulisine recombinant INJECTABLE;SUBCUTANEOUS 021629 NDA Sanofi-Aventis U.S. LLC N 0088-2502-05
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Army
Mallinckrodt
QuintilesIMS
Farmers Insurance
UBS
McKesson
Citi
McKinsey